H1-Antihistamine Up-Dosing in Chronic Spontaneous Urticaria: Patients' Perspective of Effectiveness and Side Effects – A Retrospective Survey Study
Open Access
- 1 September 2011
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 6 (9) , e23931
Abstract
The guidelines recommend that first line treatment of chronic spontaneous urticaria should be second generation non-sedating H1-antihistamines with a positive recommendation against the use of old sedating first generation antihistamines. If standard dosing is not effective, increasing the dosage up to four-fold is recommended. The objective of this study was to obtain the chronic spontaneous urticaria-patient perspective on the effectiveness and unwanted effects of H1-antihistamines in standard and higher doses. This was a questionnaire based survey, initially completed by 368 individuals. 319 (248 female, 71 male, median age 42 years) had a physician-confirmed diagnosis of chronic spontaneous urticaria and were included in the results. Participants believed standard doses (manufacturers recommended dose) of second generation antihistamines to be significantly (PPP1-antihistamines and that, if standard dosing is not effective, the dosage should be increased up to four-fold.Keywords
This publication has 26 references indexed in Scilit:
- Rupatadine and its effects on symptom control, stimulation time, and temperature thresholds in patients with acquired cold urticariaAnnals of Allergy, Asthma & Immunology, 2010
- Fexofenadine in higher doses in chronic spontaneous urticariaIndian Dermatology Online Journal, 2010
- The use of a responder analysis to identify clinically meaningful differences in chronic urticaria patients following placebo- controlled treatment with rupatadine 10 and 20 mgJournal of the European Academy of Dermatology and Venereology, 2009
- Chronic urticaria: an internet survey of health behaviours, symptom patterns and treatment needs in European adult patientsBritish Journal of Dermatology, 2009
- Clinical Pharmacokinetics and Pharmacodynamics of Desloratadine, Fexofenadine and LevocetirizineClinical Pharmacokinetics, 2008
- Chronic unremitting urticaria: is the use of antihistamines above the licensed dose effective? A preliminary study of cetirizine at licensed and above-licensed dosesClinical and Experimental Dermatology, 2006
- Comparative study of the impact of chronic urticaria, psoriasis and atopic dermatitis on the quality of lifeBritish Journal of Dermatology, 2005
- Antihistamines and driving ability: evidence from on-the-road driving studies during normal trafficAnnals of Allergy, Asthma & Immunology, 2004
- H1-receptor antagonists: safety issuesAnnals of Allergy, Asthma & Immunology, 1999
- H1-Receptor AntagonistsDrug Safety, 1994